Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
09/2010
09/02/2010WO2010099445A2 Non-covalent inhibition of the 26s proteasome and uses thereof
09/02/2010WO2010099044A2 Treatment of immunosuppression-related disorders
09/02/2010WO2010098265A1 Polymeric micelle containing proteasome inhibitor
09/02/2010WO2010098251A1 Loxoprofen derivative and pharmaceutical containing same
09/02/2010WO2010098125A1 Retinoid x receptor partial agonist compound
09/02/2010WO2010097395A1 Pyrazole derivatives used as ccr4 receptor antagonists
09/02/2010WO2010097373A1 Compounds for use as bradykinin b1 antagonists
09/02/2010WO2010097335A1 Imidazo [1, 2 -a] pyridines as jnk modulators
09/02/2010WO2010097334A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010097332A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010096854A1 Methods of modulating the activity of the mc3 and/or mc4 receptors and treatment of conditions related to these receptors
09/02/2010WO2010096853A1 Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor
09/02/2010WO2010057028A9 Treatment of proteinopathies using a farnesyl transferase inhibitor
09/02/2010WO2010034779A3 Composition and method for treatment of preterm labor
09/02/2010WO2010030757A3 Aminopyrimidine inhibitors of histamine receptors for the treatment of disease
09/02/2010WO2010006772A8 Use of cd95 inhibitors for the treatment of inflammatory disorders
09/02/2010WO2009115893A3 Novel 2 ', 2 ', 3 ', 3 ' -tetrasubstiuted nucleoside derivatives
09/02/2010WO2009114097A4 Method of modulating t cell-dependent immune responses
09/02/2010WO2009108118A9 16 alpha, 17 alpha-acetal glucocorticosteroidal derivatives and their use
09/02/2010US20100222591 New Compounds
09/02/2010US20100222437 Composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases
09/02/2010US20100222430 Method of Treating Post-Surgical Acute Pain
09/02/2010US20100222427 Pharmaceutical composition comprising oseltamivir phosphate
09/02/2010US20100222385 Selective ablation of pain-sensing neurons by administration of a vanilloid receptor agonist
09/02/2010US20100222366 Piperidine derivatives as modulators of chemokine receptor activity
09/02/2010US20100222363 Bicyclic Derivatives as P38 Inhibitors
09/02/2010US20100222358 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
09/02/2010US20100222355 Quinolizidinone m1 receptor positive allosteric modulators
09/02/2010US20100222348 Quinolinone derivatives as parp inhibitors
09/02/2010US20100222332 Pyrazolo-pyrazines derivatives used as g protein inhibitors
09/02/2010US20100222331 New compounds
09/02/2010US20100222325 Inhibitors of Bruton's Tyrosine Kinase
09/02/2010US20100222311 Solid formulations of crystalline compounds
09/02/2010US20100222308 Ophthalmic, otic or nasal pharmaceutical composition and the use thereof
09/02/2010US20100222298 Spill resistant formulations containing clays
09/02/2010US20100222290 Methods for Concomitant Administration of Colchicine and Macrolide Antibiotics
09/02/2010US20100222272 Pharmaceutical Compositions for the Treatment of TNF-Alpha Related Disorders
09/02/2010US20100222270 Heterocyclic compounds as crth2 receptor antagonists
09/02/2010US20100222262 Substituted 1, 3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions
09/02/2010US20100222258 TNF antagonist and TNF inhibitor containing it as an effective ingredient
09/02/2010US20100221746 Compositions and methods for the treatment of disease
09/02/2010US20100221372 Wolfberries and skin inflammation
09/02/2010US20100221340 Method and compositions for treatment or prevention of inflammatory conditions
09/02/2010US20100221337 Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and an h2 receptor antagonist
09/02/2010US20100221336 Method of treating arthritis, pain or inflammation with naproxen 2(methanesulfonyl)ethyl ester and a proton pump inhibitor
09/02/2010US20100221334 Compositions including leukotriene antagonists and nsaids and methods of using the same
09/02/2010US20100221331 Pharmaceutical compositions comprising colloidal silicon dioxide
09/02/2010US20100221330 Buoyant formulations of betaine
09/02/2010US20100221329 Formulations of guanylate cyclase c agonists and methods of use
09/02/2010US20100221305 Formulations for coated microprojections containing non-volatile counterions
09/02/2010US20100221298 Novel galenical system for active transport, method for preparation and use
09/02/2010US20100221261 Iap bir domain binding compounds
09/02/2010US20100221259 Nitrogen-containing heterocyclic compounds and medicinal use thereof
09/02/2010US20100221195 Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
09/02/2010CA2753604A1 Drug combinations containing pde4-inhibitors and nsaids
09/02/2010CA2753597A1 Drug combinations containing pde4-inhibitors and nsaids
09/02/2010CA2753337A1 Pyrazole derivatives used as ccr4 receptor antagonists
09/02/2010CA2749236A1 Imidazo [1,2-a] pyridines as jnk modulators
09/01/2010EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
09/01/2010EP2223920A2 Substituted azabicyclic compounds
09/01/2010EP2223703A1 External preparation composition comprising fatty acid-based ionic liquid as active ingredient
09/01/2010EP2223688A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
09/01/2010EP2223687A1 (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione: Methods of Using and Compositions Thereof
09/01/2010EP2222709A2 Antigen-binding constructs
09/01/2010EP2222706A1 Antibodies against human nkg2d and uses thereof
09/01/2010EP2222681A1 Efficient aspirin prodrugs
09/01/2010EP2222674A1 Amino triazoles as pi3k inhibitors
09/01/2010EP2222631A2 Substituted phenylmethyl bicyclocarboxyamide compounds
09/01/2010EP2222299A2 Use of levocabastine for modulating generation of pro-inflammatory cytokines
09/01/2010EP2222287A2 Multitarget compounds active at a ppar and cannabinoid receptor
09/01/2010EP2222160A2 Haloallylamine inhibitors of ssao/vap-1 and uses therefor
09/01/2010EP2057122B1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the 2 adrenergic receptor
09/01/2010EP1854787B1 Novel cyclic compound having quinolylalkylthio group
09/01/2010EP1812439B1 Kinase inhibitors
09/01/2010EP1726587B1 Benzothiazin-3-one compound and intermediate therefor
09/01/2010EP1594854B1 Thiazolyl-based compounds useful as kinase inhibitors
09/01/2010EP1583525B1 Use of porphyrin synthesis substances in combination with salicylates and antioxidants for use in phototherapy to cure skin and articulation diseases
09/01/2010EP1558614B1 Pyridopyrrolizine and pyridoindolizine derivatives
09/01/2010EP1423406B1 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina)
09/01/2010EP1028942B1 Dipeptide nitriles
09/01/2010CN101821274A Bis(trimethylsilyl)phenyl compound or salt thereof, and use thereof
09/01/2010CN101821254A Adrenergic compounds
09/01/2010CN101820914A Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient
09/01/2010CN101820913A Immunoliposome inducing apoptosis into cell expressing death domain-containing receptor
09/01/2010CN101820881A Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treament of inflammation
09/01/2010CN101820880A Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient
09/01/2010CN101820876A Method for treating acute pain with formulated drug depot in combination with liquid formulation
09/01/2010CN101817852A Preparation of composition containing primaverin and phenethyl ketoside components
09/01/2010CN101817805A Andrographolide derivative and preparation method and application thereof
09/01/2010CN101817798A Novel environment-friendly process for preparing leflunomide
09/01/2010CN101816819A Multifunctional saline-alkaline heat transfer treatment waistband and preparation method thereof
09/01/2010CN101816818A Multifunctional saline-alkaline heat transfer treatment chair and preparation method thereof
09/01/2010CN101816773A Method for measuring content of superfine powder preparation in five retentions powder
09/01/2010CN101816760A Chinese medicament for treating rheumatoid disease
09/01/2010CN101816726A Effervescent traditional Chinese medicine composition having intense heat-purging and detoxicating function and preparation method thereof
09/01/2010CN101816721A Chinese medicinal composition for treating children fever caused by exogenous pathogens and preparation method thereof
09/01/2010CN101816720A Bonesetting and collaterals activating pills
09/01/2010CN101816718A Method for producing Dafeng pills for treating low back pain by utilizing micro-powder technology
09/01/2010CN101816713A Garden balsam stem pain-relieving paste
09/01/2010CN101816712A Chinese medicinal composition for treating trigeminal neuralgia
1 ... 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 ... 1272